Axxcess Wealth Management LLC Takes $217,000 Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Axxcess Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF (NYSEARCA:XBI) in the 4th quarter, Holdings Channel reports. The institutional investor acquired 2,435 shares of the exchange traded fund’s stock, valued at approximately $217,000.

A number of other institutional investors and hedge funds have also recently bought and sold shares of the stock. Financial Advocates Investment Management bought a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at $232,000. WP Advisors LLC increased its position in shares of SPDR S&P Biotech ETF by 2.4% in the third quarter. WP Advisors LLC now owns 12,687 shares of the exchange traded fund’s stock worth $926,000 after acquiring an additional 303 shares in the last quarter. Perigon Wealth Management LLC increased its position in shares of SPDR S&P Biotech ETF by 32.4% in the third quarter. Perigon Wealth Management LLC now owns 6,219 shares of the exchange traded fund’s stock worth $454,000 after acquiring an additional 1,521 shares in the last quarter. Congress Wealth Management LLC DE raised its holdings in shares of SPDR S&P Biotech ETF by 3.9% during the third quarter. Congress Wealth Management LLC DE now owns 281,256 shares of the exchange traded fund’s stock valued at $20,537,000 after acquiring an additional 10,565 shares during the period. Finally, Abundance Wealth Counselors lifted its position in shares of SPDR S&P Biotech ETF by 3.3% in the 3rd quarter. Abundance Wealth Counselors now owns 21,890 shares of the exchange traded fund’s stock valued at $1,598,000 after acquiring an additional 700 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

NYSEARCA XBI opened at $89.02 on Friday. The firm’s 50 day moving average price is $91.25 and its two-hundred day moving average price is $85.82. SPDR S&P Biotech ETF has a twelve month low of $63.80 and a twelve month high of $103.52. The stock has a market cap of $6.79 billion, a price-to-earnings ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.